rhuil-1 beta alone or in combination with rhug-csf or recombinant murine gm-csf significantly improved tumor growth inhibition ( 60 % vs. 90 % ) and survival ( 20 % vs. 90 % -100 % ) , increased the maximally tolerated dose of 5-fu , accelerated recovery of neutrophil counts in peripheral blood , and reduced duration of significant neutropenia and loss of body weight ( 29 % vs. 10 % loss ) .
C0021753
rhuil-1 beta
C0086418
rhuil-1 beta